It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The progression of human degenerative and hypoxic/ischemic diseases is accompanied by widespread cell death. One death process linking iron-catalyzed reactive species with lipid peroxidation is ferroptosis, which shows hallmarks of both programmed and necrotic death in vitro. While evidence of ferroptosis in neurodegenerative disease is indicated by iron accumulation and involvement of lipids, a stable marker for ferroptosis has not been identified. Its prevalence is thus undetermined in human pathophysiology, impeding recognition of disease areas and clinical investigations with candidate drugs. Here, we identified ferroptosis marker antigens by analyzing surface protein dynamics and discovered a single protein, Fatty Acid-Binding Protein 5 (FABP5), which was stabilized at the cell surface and specifically elevated in ferroptotic cell death. Ectopic expression and lipidomics assays demonstrated that FABP5 drives redistribution of redox-sensitive lipids and ferroptosis sensitivity in a positive-feedback loop, indicating a role as a functional biomarker. Notably, immunodetection of FABP5 in mouse stroke penumbra and in hypoxic postmortem patients was distinctly associated with hypoxically damaged neurons. Retrospective cell death characterized here by the novel ferroptosis biomarker FABP5 thus provides first evidence for a long-hypothesized intrinsic ferroptosis in hypoxia and inaugurates a means for pathological detection of ferroptosis in tissue.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 Helmholtz Zentrum Munich, Genetics and Cellular Engineering Group, Research Unit Signaling and Translation, Neuherberg, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525)
2 Helmholtz Zentrum Munich, Genetics and Cellular Engineering Group, Research Unit Signaling and Translation, Neuherberg, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525); Yale University School of Medicine, Department of Genetics, New Haven, USA (GRID:grid.47100.32) (ISNI:0000 0004 1936 8710)
3 Helmholtz Zentrum Munich, Research Unit Analytical BioGeoChemistry, Neuherberg, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525)
4 Helmholtz Zentrum Munich, Metabolomics and Proteomics Core, Neuherberg, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525)
5 Center for Neuropathology and Prion Research, Munich, Germany (GRID:grid.4567.0)
6 Goethe University, Institute of Neurology (Edinger Institute), Frankfurt am Main, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721)
7 Goethe University, Institute of Neurology (Edinger Institute), Frankfurt am Main, Germany (GRID:grid.7839.5) (ISNI:0000 0004 1936 9721); Birla Institute of Science and Technology Pilani, Department of Biological Sciences, Hyderabad, India (GRID:grid.418391.6) (ISNI:0000 0001 1015 3164)
8 Helmholtz Zentrum Munich, Genetics and Cellular Engineering Group, Research Unit Signaling and Translation, Neuherberg, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525); Zaporizhzhia State Medical and Pharmaceutical University, Physical and Colloidal Chemistry Department, Pharmaceutical Faculty, Zaporizhzhia, Ukraine (GRID:grid.4567.0)
9 Center for Neuropathology and Prion Research, Munich, Germany (GRID:grid.4567.0); Ludwig-Maximilians-University Munich, Department of Psychiatry and Psychotherapy, University Hospital, Munich, Germany (GRID:grid.5252.0) (ISNI:0000 0004 1936 973X)